BENESTERMYCIN (20+56+20)MG/ML ενδομαστικό εναιώρημα
BENESTERMYCIN (20+56+20)MG/ML ενδομαστικό εναιώρημα
Authorised
- Penethamate hydriodide
- Benethamine penicillin
- Framycetin sulfate
Product identification
Medicine name:
BENESTERMYCIN (20+56+20)MG/ML ενδομαστικό εναιώρημα
Active substance:
- Penethamate hydriodide
- Benethamine penicillin
- Framycetin sulfate
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Penethamate hydriodide20.00/milligram(s)1.00millilitre(s)
-
Benethamine penicillin56.00/milligram(s)1.00millilitre(s)
-
Framycetin sulfate20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
-
Meat and offal9day
-
Milk36hourεάν χορηγηθεί τουλάχιστον 35 ημέρες πριν από τον τοκετό
-
Milk37dayεάν χορηγηθεί σε διάστημα μικρότερο από 35 ημέρες πριν από τον τοκετό
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC25
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lohmann Pharma Herstellung GmbH
- Haupt Pharma Latina S.r.l.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 18393/04-06-2013/Κ-0096801
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
